Zevalin shows positive results in study
IRVINE, Calif. Spectrum Pharmaceuticals Inc. said its drug Zevalin showed positive results in a midstage study focusing on a type of cancer called follicular lymphoma.
AstraZeneca PLC on Monday reported a positive result in a Phase III study of its thyroid cancer drug.